Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07381049 · ClinicalTrials.gov registry record · NA

Effect of Cash Benefits on Health Care Spending

A NA study of Health Care Utilization and Health Care Costs, sponsored by Harvard Medical School (HMS and HSDM).

Active
Registry status
NA
Development phase
3,615
Enrollment target
3
Study locations

NCT07381049 is a NA study of Health Care Utilization and Health Care Costs that is active but no longer recruiting, run by Harvard Medical School (HMS and HSDM). The registered enrollment target is 3,615 participants, above the 777-participant average among 25 other Health Care Utilization trials with a reported enrollment target (365% higher). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07381049, a NA study of Health Care Utilization and Health Care Costs, is active but no longer recruiting, sponsored by Harvard Medical School (HMS and HSDM).

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
3,615 participants
Enrollment target
3
Study locations

Study Summary

During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate monthly cash benefits to its residents. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on health care spending.

Interventions

  • OTHER Cash Benefit
  • OTHER No Cash Benefit

Study Locations (3)

Massachusetts

  • Brigham and Women's Hospital / Harvard Medical School - Boston
  • Harvard University - Cambridge

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 3,615 participants
Start Date 2020-07-27
Est. Completion 2026-12
Phase NA

What the Registry Record Tells You About NCT07381049

The ClinicalTrials.gov registry entry for NCT07381049 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 3,615 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 777-participant average among 25 other Health Care Utilization trials with a reported enrollment target (365% higher). The listed sponsor is Harvard Medical School (HMS and HSDM), which has 26 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Health Care Utilization appearing as the primary indexed condition, and to 2 interventions - of which Cash Benefit is the first listed.

NCT07381049 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Michigan.

Frequently Asked Questions

What is clinical trial NCT07381049 about?

NCT07381049 is a clinical study titled "Effect of Cash Benefits on Health Care Spending". During the first two years of the COVID-19 pandemic, the City of Chelsea, Massachusetts held a lottery to allocate monthly cash benefits to its residents. Using data from the Chelsea Eats program, the investigators propose to study the impact of the cash benefit on health care spending.

What is the current status of trial NCT07381049?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,615 participants. The study started on 2020-07-27. Estimated completion is 2026-12.

What conditions does trial NCT07381049 study?

This clinical trial studies the following conditions: Health Care Utilization, Health Care Costs.

What interventions are being tested in trial NCT07381049?

The interventions under investigation include: Cash Benefit (OTHER), No Cash Benefit (OTHER).

Who is sponsoring clinical trial NCT07381049?

This trial is sponsored by Harvard Medical School (HMS and HSDM), which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07381049 being conducted?

This trial has 3 study locations across Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Health Care Utilization

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.